HTX have competition from the yale dept of obstetrics which...

HTX have competition from the yale dept of obstetrics which released a 99% accuracy on early stage ovarian cancer from another phase 2 trial on Feb 12th.

however six protein bimarkers are needed from the yale test so could be more tricky to commercialise I am guessing
http://www.sciencedaily.com/releases/2008/02/080212144500.htm

I think there is a company dong a urine test as well.

Have to agree the market is bigger than stated due to current test CA125 poor results